Khosla Impact

Regie.ai is a technology company that specializes in AI-powered sales engagement platforms. Its flagship product, RegieOne, automates outbound prospecting tasks, enhancing workflow efficiency for operations teams. The platform integrates sales engagement, parallel dialing, data enrichment, and intent data analysis, providing users with a centralized view of their processes. Additionally, Regie.ai offers an AI content platform that creates, tests, and analyzes personalized prospecting sales campaigns, aiming to boost engagement and optimize front-line performance.

C the Signs is a cancer prediction system that empowers general practitioners to efficiently assess combinations of clinical signs, symptoms, and risk factors to identify patients at risk of cancer at its earliest and most treatable stages. The platform analyzes multiple diagnostic pathways, allowing physicians to make informed decisions during consultations, when the potential to influence patient outcomes is highest. By facilitating quick assessments, C the Signs enables doctors to recommend necessary investigations or urgent referrals in under 30 seconds, ultimately aiming to enhance early detection and improve survival rates for cancer patients.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Distyl AI is a company focused on enhancing organizational readiness for artificial intelligence and developing customized AI-based solutions. By leveraging its proprietary generative AI solutions platform, Distyl collaborates with institutions globally to facilitate the adoption of foundation models and improve AI integration into existing workflows. The company tailors its services to meet the specific data and operational needs of each client, ensuring that they can effectively navigate and thrive in an AI-driven economy. Through its efforts, Distyl aims to equip enterprises with the tools necessary for successful AI implementation and utilization.

Profound offers cutting-edge technology that analyzes how AI platforms portray and discuss brands, assisting businesses in managing their online reputation. The platform enables companies to oversee and comprehend their brand's representation in AI-generated responses, ensuring a favorable image. Profound functions as a robust analytics tool tailored for enterprise brands, aimed at improving their visibility and effectiveness in AI search environments.

Nabla Bio is a biotechnology company that specializes in the development of an autoreverse platform for the discovery of innovative protein variants. These proteins, which exhibit unique qualities, are engineered to create new medicines and enhance nutritional products. By leveraging insights gained from billions of natural proteins, Nabla Bio enhances these variants through extensive experimentation, allowing for advanced applications in both medical and industrial fields. The company's focus on complex measurements of protein function positions it as a leader in the pursuit of previously unattainable protein capabilities.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Advocate is a technology company that specializes in developing artificial intelligence applications to enhance interactions between government agencies and civilians. Its platform is designed to automate filing and response processes, thereby streamlining human processing, decision-making, and risk assessment for federal government benefits programs. By focusing on improving efficiency and effectiveness, Advocate aims to facilitate a more transparent and accessible application process for disabled Americans seeking government benefits. The company's services are intended to create a hassle-free experience for qualified claimants, ensuring that financial support is readily available to those who need it.

Gather Health is an international healthcare technology company dedicated to empowering chronic disease patients to enhance their health. The company develops mobile and cloud-based healthcare applications that utilize cutting-edge medical and behavioral research to motivate and educate patients. By connecting physicians, patients, their families, and communities, Gather Health aims to provide continuous and holistic care that leads to improved health outcomes. The rise in chronic diseases such as obesity, diabetes, and hypertension has created a pressing need for effective patient care solutions, especially given the shortage of healthcare providers. Gather Health's flagship product, the Gather Health Diabetes platform, is currently utilized by physicians and patients in various cities across Hong Kong and India, including Mumbai and Bangalore, demonstrating positive health outcomes for users. Headquartered in Hong Kong, with additional offices in Beijing, New York, and India, the company boasts a diverse team of clinicians, health experts, interaction designers, and engineers experienced in the global healthcare landscape.

Regie.ai is a technology company that specializes in AI-powered sales engagement platforms. Its flagship product, RegieOne, automates outbound prospecting tasks, enhancing workflow efficiency for operations teams. The platform integrates sales engagement, parallel dialing, data enrichment, and intent data analysis, providing users with a centralized view of their processes. Additionally, Regie.ai offers an AI content platform that creates, tests, and analyzes personalized prospecting sales campaigns, aiming to boost engagement and optimize front-line performance.

Mirvie is a biotechnology company specializing in non-invasive tests for maternal-fetal health, aimed at enhancing the safety of pregnancy. Founded in 2018 by Maneesh Jain and based in South San Francisco, California, Mirvie provides predictive diagnostic tools that deliver actionable insights to expectant mothers and families. Its medical diagnostic platform enables healthcare practitioners to identify at-risk pregnancies, facilitating timely interventions and therapeutic approaches to improve pregnancy outcomes. Through its innovative solutions, Mirvie seeks to empower families with critical information, ensuring a safer pregnancy experience.

Myko AI is an artificial intelligence tool that pulls financial data from spreadsheets and helps make successful revenue-generating decisions with minimum onboarding. The company's application integrates directly into users' existing CRM platforms and chat applications, allowing data to be analyzed in seconds. This enables businesses to drive more revenue by providing their teams with deeper analytical capabilities and improving the financial reporting process by spending less time copying and pasting data.

Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Nabla Bio is a biotechnology company that specializes in the development of an autoreverse platform for the discovery of innovative protein variants. These proteins, which exhibit unique qualities, are engineered to create new medicines and enhance nutritional products. By leveraging insights gained from billions of natural proteins, Nabla Bio enhances these variants through extensive experimentation, allowing for advanced applications in both medical and industrial fields. The company's focus on complex measurements of protein function positions it as a leader in the pursuit of previously unattainable protein capabilities.

Gaiascope, Inc. is a software-as-a-service company based in Brooklyn, New York, that specializes in developing innovative analytics solutions for the energy industry. Founded in 2019, Gaiascope employs machine learning techniques to analyze large datasets, enabling energy companies and investors to better understand and navigate the complexities of the electric grid. Their user-friendly software provides critical insights, including locational marginal pricing, grid constraints, and demand forecasts, facilitating more informed decision-making in real-time trading, operations, and development. Gaiascope emphasizes transparency in its tools, which are designed to optimize the management of power markets while addressing the challenges posed by increasing renewable energy integration and evolving market dynamics.

NetSpring is a company that specializes in product and customer journey analytics, providing tools to analyze product usage, user behavior, and customer experiences across various channels. Their platform is designed for contemporary data environments, allowing for warehouse-native analytics that eliminates the need for data duplication. By enabling product, growth, and data teams to access deeper insights directly from data warehouses, NetSpring helps businesses prioritize feature development, optimize customer acquisition, and reduce churn. The company's offerings empower organizations to enhance their products and overall customer experiences through detailed analysis of user behavior and product interaction trends.

Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Invoy is a company focused on enhancing health and weight loss outcomes through the integration of science, data, and artificial intelligence. It develops a monitoring medical device that offers personalized nutrition and wellness services by generating real-time data on an individual's metabolism. This device not only provides tailored, predictive nutrition recommendations but also features affordable breath analyzers for medical applications. By addressing the unique body chemistry of each individual, Invoy aims to empower users to achieve their specific health and wellness objectives.

Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

NetSpring is a company that specializes in product and customer journey analytics, providing tools to analyze product usage, user behavior, and customer experiences across various channels. Their platform is designed for contemporary data environments, allowing for warehouse-native analytics that eliminates the need for data duplication. By enabling product, growth, and data teams to access deeper insights directly from data warehouses, NetSpring helps businesses prioritize feature development, optimize customer acquisition, and reduce churn. The company's offerings empower organizations to enhance their products and overall customer experiences through detailed analysis of user behavior and product interaction trends.

BioAge Labs, Inc. is a biotechnology company focused on developing therapies to treat aging and age-related diseases. The company utilizes a proprietary systems biology and artificial intelligence platform to identify significant drug targets that influence aging, leveraging extensive datasets to uncover the molecular drivers of age-related pathologies. Among its key offerings is BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor that activates HIF-1 target genes involved in various biological processes, including tissue regeneration and vascular remodeling. Another notable product is BGE-175, an orally administered inhibitor targeting the prostaglandin D2 DP1 signaling pathway, which is linked to an increased risk of mortality and infections, including those associated with immune aging. Founded in 2015 and headquartered in Richmond, California, BioAge Labs is dedicated to harnessing the biology of human aging to create innovative therapies for metabolic and age-related diseases.

Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.

Mirvie is a biotechnology company specializing in non-invasive tests for maternal-fetal health, aimed at enhancing the safety of pregnancy. Founded in 2018 by Maneesh Jain and based in South San Francisco, California, Mirvie provides predictive diagnostic tools that deliver actionable insights to expectant mothers and families. Its medical diagnostic platform enables healthcare practitioners to identify at-risk pregnancies, facilitating timely interventions and therapeutic approaches to improve pregnancy outcomes. Through its innovative solutions, Mirvie seeks to empower families with critical information, ensuring a safer pregnancy experience.

Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Xcalar, Inc. is a data infrastructure services company based in San Jose, California, founded in 2013. It provides a business analytics platform that enables users to extract meaningful insights directly from petabytes of raw data without the need for data preparation or movement, thanks to its patented True Data In Place technology. This innovative approach allows for fundamental discovery of insights at unprecedented speed and scale, significantly reducing the time required to analyze complex datasets. Xcalar's platform simplifies the management, modeling, and analysis of big data, making it an essential tool for modern data applications, business intelligence, and reporting tools. By eliminating the need for data shuffling, Xcalar enhances efficiency and accessibility, facilitating a more straightforward pathway to uncover valuable information from extensive data resources.

NMLStream is a technology company that specializes in artificial intelligence solutions for information technology management. The company has developed decision-making software aimed at enhancing performance monitoring and automating actions across various computing environments, including cloud, on-premises, and hybrid systems. By utilizing AI, NMLStream's software generates a unified digital language that describes system behaviors, facilitating improved collaboration among IT teams. This approach enables organizations to optimize their performance and maximize application uptime, ultimately enhancing overall operational efficiency.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

PatternEx, Inc. is a technology company that specializes in developing artificial intelligence software aimed at enhancing cybersecurity measures. Founded in 2013 and based in San Jose, California, it focuses on identifying malicious user intent to predict and prevent cyber-attacks across enterprises in real time. The company's Virtual Analyst Platform plays a crucial role in transforming log data from multiple sources into actionable behaviors, utilizing AI Pipelines for in-depth analysis. This platform significantly improves attack detection accuracy and minimizes false positives, allowing organizations to concentrate on meaningful alerts. Key features include AutoCorrelate, which expedites threat investigations by twenty times, and custom analytics that empower users to perform tailored analysis on raw logs. By integrating AI with human analyst insights, PatternEx aims to redefine the landscape of information security, making it more effective and efficient.

Cylance Inc. is a cybersecurity company that specializes in artificial intelligence-driven security solutions designed to predict and prevent advanced threats and malware. Founded in 2012 and based in Irvine, California, Cylance employs a unique mathematical approach and machine learning to rapidly identify potential threats, differentiating itself by focusing on proactive security measures rather than traditional blacklist methods. The company's offerings include protection against various attack vectors such as malware, ransomware, and fileless malware, as well as services like threat hunting, incident response, and consulting. Cylance's solutions are utilized across multiple industries, including critical infrastructure, healthcare, finance, and education, aiming to enhance the security posture of businesses and government entities. In 2019, Cylance became a subsidiary of BlackBerry Limited, further expanding its capabilities in the cybersecurity landscape.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Xcalar, Inc. is a data infrastructure services company based in San Jose, California, founded in 2013. It provides a business analytics platform that enables users to extract meaningful insights directly from petabytes of raw data without the need for data preparation or movement, thanks to its patented True Data In Place technology. This innovative approach allows for fundamental discovery of insights at unprecedented speed and scale, significantly reducing the time required to analyze complex datasets. Xcalar's platform simplifies the management, modeling, and analysis of big data, making it an essential tool for modern data applications, business intelligence, and reporting tools. By eliminating the need for data shuffling, Xcalar enhances efficiency and accessibility, facilitating a more straightforward pathway to uncover valuable information from extensive data resources.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Cylance Inc. is a cybersecurity company that specializes in artificial intelligence-driven security solutions designed to predict and prevent advanced threats and malware. Founded in 2012 and based in Irvine, California, Cylance employs a unique mathematical approach and machine learning to rapidly identify potential threats, differentiating itself by focusing on proactive security measures rather than traditional blacklist methods. The company's offerings include protection against various attack vectors such as malware, ransomware, and fileless malware, as well as services like threat hunting, incident response, and consulting. Cylance's solutions are utilized across multiple industries, including critical infrastructure, healthcare, finance, and education, aiming to enhance the security posture of businesses and government entities. In 2019, Cylance became a subsidiary of BlackBerry Limited, further expanding its capabilities in the cybersecurity landscape.

Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

LiftIgniter is a San Francisco-based company specializing in machine learning-based personalization solutions. Its core offering is a personalization API that facilitates intelligent, real-time interactions across various customer touchpoints. By employing data science techniques, LiftIgniter's platform optimizes key metrics such as click-through rates, engagement, sharing, and conversion for businesses. The technology effectively analyzes user actions and responds with tailored recommendations, enhancing the overall customer experience. This dynamic learning capability allows businesses to better connect with their customers, improve communication, and ultimately drive sales. LiftIgniter was part of the Winter 2014 YCombinator class, underscoring its innovative approach in the field of personalized digital interactions.

Metamarkets Group operates an interactive analytics platform designed for buyers and sellers of programmatic advertising. Founded in 2010 and headquartered in San Francisco, California, the company provides users with the capability to analyze real-time data within media marketplaces, enhancing their competitive edge. Its platform is utilized by notable clients such as Twitter, AOL, and Rubicon Project, enabling them to improve business performance through intuitive access to critical information. Metamarkets emphasizes self-service permissions for data and secure data transfers, empowering marketers with ad hoc data navigation and visualization tools to make informed decisions in the digital advertising landscape.

DB CyberTech is a cybersecurity company specializing in predictive data loss prevention technologies designed to safeguard business data. Founded in 2009 and headquartered in San Diego, California, the company leverages advanced techniques such as deep protocol extraction, machine learning, and behavioral analysis to assess database infrastructures. Its innovative products enable non-intrusive monitoring and analysis of database activity, allowing organizations to accurately identify insider threats and database attacks. DB CyberTech serves a diverse clientele, including major financial institutions, healthcare providers, manufacturers, and government entities. The company's solutions provide detailed insights into application and database interactions, enhancing situational awareness and helping clients protect sensitive information from potential breaches.

Quantopian, Inc. is an online platform that facilitates the development and testing of quantitative trading algorithms. Established in 2011 and based in Boston, Massachusetts, the company offers a comprehensive suite of tools and infrastructure that enables users to learn about quantitative finance, engage in community discussions, and explore algorithms created by other members. The platform allows users to create and backtest their own algorithms, analyze results, and evaluate risk metrics. Quantopian also fosters an engaged community of approximately 195,000 quants, who share insights and learn from each other. The company provides capital for algorithm authors to trade, both through monthly contests and a selection process aimed at high-quality strategies. By combining education, data, and a collaborative research environment, Quantopian inspires individuals worldwide to innovate in algorithmic investing.

Tule is a technology company specializing in precision agriculture. It offers an automated irrigation management platform that uses proprietary sensors licensed from UC Davis to measure actual evapotranspiration across large areas, not just at individual plants. The platform provides real-time data and weekly forecasts via a dashboard, enabling farmers to make informed decisions about when and how much to irrigate their crops. Key features include 24/7 evapotranspiration monitoring, field-level water stress tracking, and performance comparison across different fields.

ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

Cylance Inc. is a cybersecurity company that specializes in artificial intelligence-driven security solutions designed to predict and prevent advanced threats and malware. Founded in 2012 and based in Irvine, California, Cylance employs a unique mathematical approach and machine learning to rapidly identify potential threats, differentiating itself by focusing on proactive security measures rather than traditional blacklist methods. The company's offerings include protection against various attack vectors such as malware, ransomware, and fileless malware, as well as services like threat hunting, incident response, and consulting. Cylance's solutions are utilized across multiple industries, including critical infrastructure, healthcare, finance, and education, aiming to enhance the security posture of businesses and government entities. In 2019, Cylance became a subsidiary of BlackBerry Limited, further expanding its capabilities in the cybersecurity landscape.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Kyron, Inc. is a company based in Palo Alto, California, that specializes in the analysis of medical records from routine care to generate valuable medical insights. Established in 2013, Kyron focuses on identifying latent associations among medical conditions, interventions, and outcomes, thereby producing practice-based evidence. Through its medical records analysis platform, the company enables healthcare providers and individuals to collaborate in making informed decisions, ultimately aimed at enhancing health outcomes and improving the quality of healthcare.

Quantopian, Inc. is an online platform that facilitates the development and testing of quantitative trading algorithms. Established in 2011 and based in Boston, Massachusetts, the company offers a comprehensive suite of tools and infrastructure that enables users to learn about quantitative finance, engage in community discussions, and explore algorithms created by other members. The platform allows users to create and backtest their own algorithms, analyze results, and evaluate risk metrics. Quantopian also fosters an engaged community of approximately 195,000 quants, who share insights and learn from each other. The company provides capital for algorithm authors to trade, both through monthly contests and a selection process aimed at high-quality strategies. By combining education, data, and a collaborative research environment, Quantopian inspires individuals worldwide to innovate in algorithmic investing.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Judicata specializes in transforming unstructured court opinions into structured data through advanced case law parsing and algorithm-assisted review. The company develops legal research and analytics tools designed to provide attorneys with critical information that enhances their ability to achieve successful outcomes for their clients. By offering intuitive navigation options, Judicata allows legal professionals to efficiently search for specific cases, such as race discrimination, and apply various filters based on factual, contextual, and procedural details. This innovative approach enables lawyers to manage large volumes of information effectively, supporting their judgment and decision-making in legal matters.

Evolv is a big data company that helps solve workforce performance issues for the C-suite by utilizing a configurable cloud services platform. Evolv's patent-pending technology platform unifies and supplements existing data from current systems, then utilizes that dataset to identify fact-based workforce insights that drive measurable ROI. By using objective, data-driven methodology, Evolv helps companies uncover the core reasons behind workforce performance, enabling executives to make better operational business decisions that generally result in tens of millions of dollars in measureable value per year.

Cylance Inc. is a cybersecurity company that specializes in artificial intelligence-driven security solutions designed to predict and prevent advanced threats and malware. Founded in 2012 and based in Irvine, California, Cylance employs a unique mathematical approach and machine learning to rapidly identify potential threats, differentiating itself by focusing on proactive security measures rather than traditional blacklist methods. The company's offerings include protection against various attack vectors such as malware, ransomware, and fileless malware, as well as services like threat hunting, incident response, and consulting. Cylance's solutions are utilized across multiple industries, including critical infrastructure, healthcare, finance, and education, aiming to enhance the security posture of businesses and government entities. In 2019, Cylance became a subsidiary of BlackBerry Limited, further expanding its capabilities in the cybersecurity landscape.

DB CyberTech is a cybersecurity company specializing in predictive data loss prevention technologies designed to safeguard business data. Founded in 2009 and headquartered in San Diego, California, the company leverages advanced techniques such as deep protocol extraction, machine learning, and behavioral analysis to assess database infrastructures. Its innovative products enable non-intrusive monitoring and analysis of database activity, allowing organizations to accurately identify insider threats and database attacks. DB CyberTech serves a diverse clientele, including major financial institutions, healthcare providers, manufacturers, and government entities. The company's solutions provide detailed insights into application and database interactions, enhancing situational awareness and helping clients protect sensitive information from potential breaches.

tenXer is a company focused on enhancing personal productivity through a data-driven platform designed for individual employees. Founded by Jeff Ma, who is also known for his involvement in the story behind the film 21, tenXer aims to address the needs of everyday workers rather than upper management. The platform collects data from various tools and services that users already engage with, presenting this information in an engaging format. By combining productivity analytics with social and game-like motivational systems, tenXer helps users gain insights into their work habits, thereby fostering intrinsic motivation and improving overall performance. This innovative approach positions tenXer as a significant player in the human capital management industry, emphasizing the importance of individual contributions to organizational productivity.

Metamarkets Group operates an interactive analytics platform designed for buyers and sellers of programmatic advertising. Founded in 2010 and headquartered in San Francisco, California, the company provides users with the capability to analyze real-time data within media marketplaces, enhancing their competitive edge. Its platform is utilized by notable clients such as Twitter, AOL, and Rubicon Project, enabling them to improve business performance through intuitive access to critical information. Metamarkets emphasizes self-service permissions for data and secure data transfers, empowering marketers with ad hoc data navigation and visualization tools to make informed decisions in the digital advertising landscape.

ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

Incredible Labs, Inc. is a San Francisco-based company founded in 2011 that specializes in artificial intelligence software. The firm is best known for developing Donna, a mobile anticipatory assistant designed to predict and address users' needs proactively. Through its innovative approach, Incredible Labs aims to enhance personal productivity and streamline daily tasks by leveraging advanced AI technology.

Kaggle Inc. is a prominent platform for data prediction competitions, catering to a diverse range of industries including pharmaceuticals, financial services, energy, and retail. Founded in 2010 and based in San Francisco, the company allows organizations to post their data for analysis by a global community of data scientists. Through its competitions, Kaggle fosters collaboration and innovation in solving complex data science problems, utilizing advanced machine learning techniques. In addition to hosting competitions, Kaggle offers tools such as Kaggle Prospect, which assists companies and governments in transforming their data sets into actionable insights. As a subsidiary of Google, Kaggle serves both domestic and international clients, delivering cutting-edge business results and addressing real-world challenges across various sectors.

Evolv is a big data company that helps solve workforce performance issues for the C-suite by utilizing a configurable cloud services platform. Evolv's patent-pending technology platform unifies and supplements existing data from current systems, then utilizes that dataset to identify fact-based workforce insights that drive measurable ROI. By using objective, data-driven methodology, Evolv helps companies uncover the core reasons behind workforce performance, enabling executives to make better operational business decisions that generally result in tens of millions of dollars in measureable value per year.

Hunch is a consumer web application that is building the "taste graph" of the internet, mapping every person on the internet to every entity on the internet and their affinity for that entity. An entity could be a web site, a cookbook, a hotel room, a celebrity, a restaurant, etc. Hunch creates a taste profile by asking them a series of questions which range from serious to profound and subsequently can make recommendations personalized to that user, which live in "topics". Topics vary widely, from entertaining subjects like 'Which superhero would you be' to more conventional questions like 'Should I Switch to A Mac?' The system then uses the answers to these questions to offer the user a suggested solution, a "hunch" of what the user would like.